Keyword: Johnson & Johnson

News

Trump Disbands Advisory Panels as More Quit

17.08.2017 - US President Donald Trump disbanded his US Manufacturing Council on Aug. 16, a day after the exodus of US Merck’s CEO Kenneth Frazier in protest over remarks made by the president...

News

US Merck CEO Quits Trump’s Council

16.08.2017 - Kenneth Frazier, CEO of Merck & Co, the third largest US pharmaceutical manufacturer, has resigned from US President Donald Trump’s manufacturing council after criticizing what he...

News

US Court Ruling May Curb Drug Suit “Tourism”

26.06.2017 - Last week’s 8-1 ruling by the US Supreme Court in a long-running case brought against Bristol-Myers Squibb (BMS) and California-based drug distributor McKesson Corp – which could...

News

Multinationals Back US Climate Leadership Council

22.06.2017 - Leading international companies including ExxonMobil, Total, BP, Johnson & Johnson and Procter & Gamble among others, have joined a US campaign against climate change that was...

News

Bayer and J&J Win Second Xarelto Trial

15.06.2017 - A federal court in New Orleans, Louisiana, has cleared manufacturer Bayer and its US marketing partner Johnson & Johnson of liability in the second trial of what is expected to be...

News

J&J Loses Latest Cancer Claim Lawsuit

09.05.2017 - US healthcare giant Johnson & Johnson (J&J) has said it will appeal the verdict of a jury in St. Louis, Missouri, ordering the company to pay more than $110 million in damages to a...

News

J&J and Bayer Win First Xarelto Lawsuit

05.05.2017 - Bayer and Johnson & Johnson have won the first of around 18,000 lawsuits lawsuit being brought by US patients who claim the blood-thinning drug Xarelto caused their uncontrollable...

Plant Construction & Process Technology

Bioelectronic Medicines: A New Type of Personalization

27.04.2017 - Bioelectronic technologies for modulating the signaling capabilities of the nervous system could pose challenges for producers of medicinal materials and chemicals – but also for...